Add like
Add dislike
Add to saved papers

Syntheses, photoluminescence, and electroluminescence of a series of iridium complexes with trifluoromethyl-substituted 2-phenylpyridine as the main ligands and tetraphenylimidodiphosphinate as the ancillary ligand.

Five bis-cyclometalated iridium complexes with tifluoromethyl-substituted 2-phenylpyridine (ppy) at different positions of its phenyl group as the main ligands and tetraphenylimidodiphosphinate (tpip) as the ancillary ligand, 2-6 (1 is a trifluoromethyl-free complex), were prepared, and their X-ray crystallography, photoluminescence, and electrochemistry were investigated. The number and positions of trifluoromethyl groups at the phenyl ring of ppy greatly affected the emission spectra of Ir(3+) complexes, and their corresponding emission peaks at 533, 502, 524, 480, and 542 nm were observed at room temperature, respectively. Constructed with complexes 2-6 as the emitters, respectively, the organic light-emitting diodes (OLEDs) with the structure of indium-tin oxide/1,1-bis[4-(di-p-tolylamino)phenyl]cyclohexane (30 nm)/Ir (x wt %):bis[3,5-bis(9H-carbazol-9-yl)phenyl]diphenylsilane (15 nm)/1,3,5-tris(1-phenyl-1H-benzo[d]imidazol-2-yl)phenyl (45 nm)/LiF (1 nm)/Al (100 nm) showed good performances. Particularly, device G4 based on 4-trifluoromethyl-substituted complex 4 with x = 8 wt % obtained a maximum luminance of over 39000 cd m(-2) and maximum luminance efficiency (η(L)) and power efficiency (η(p)) of 50.8 cd A(-1) and 29.0 lm W(-1), respectively. The results suggested that all of the complexes 2-6 would have potential applications in OLEDs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app